Slate Path Capital’s Hippo Holdings Inc. Redeemable warrants, each whole warrant exercisable for one twenty-fifth (1/25) share of Common Stock at an exercise price of $287.50 per full share HIPO.WS Stock Holding History
Bought
Maintained
Sold
Other funds holding HIPO.WS
Slate Path Capital's HIPO.WS Position: Q3 2024 in Review
Slate Path Capital sold out of Hippo Holdings Inc. Redeemable warrants, each whole warrant exercisable for one twenty-fifth (1/25) share of Common Stock at an exercise price of $287.50 per full share (HIPO.WS) in Q3 2024, closing a stake of 350,000 shares — an estimated $7.74K sold.
Slate Path Capital first reported a position in HIPO.WS in Q3 2021 and held it in 12 quarters. The position peaked at $322K in Q3 2021. 2 funds tracked by Wall St. Rank hold HIPO.WS as of Q3 2024.
- Slate Path Capital reported no remaining Hippo Holdings Inc. Redeemable warrants, each whole warrant exercisable for one twenty-fifth (1/25) share of Common Stock at an exercise price of $287.50 per full share position as of Q3 2024 after selling out during the quarter.
- Slate Path Capital sold 350,000 Hippo Holdings Inc. Redeemable warrants, each whole warrant exercisable for one twenty-fifth (1/25) share of Common Stock at an exercise price of $287.50 per full share shares in Q3 2024, an estimated $7.74K.
- Slate Path Capital first reported a position in Hippo Holdings Inc. Redeemable warrants, each whole warrant exercisable for one twenty-fifth (1/25) share of Common Stock at an exercise price of $287.50 per full share in Q3 2021 and held it in 12 quarters.
- Slate Path Capital's Hippo Holdings Inc. Redeemable warrants, each whole warrant exercisable for one twenty-fifth (1/25) share of Common Stock at an exercise price of $287.50 per full share position peaked at $322K in Q3 2021.
- 2 funds tracked by Wall St. Rank held Hippo Holdings Inc. Redeemable warrants, each whole warrant exercisable for one twenty-fifth (1/25) share of Common Stock at an exercise price of $287.50 per full share as of Q3 2024.
Based on Slate Path Capital's 13F filing for Q3 2024, filed 14 Nov 2024.